Search | Clinical Trials Finder

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 6:08 PM EDT

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 3,258 matching trials from the local directory fallback.

Filters: Not yet recruiting Clear all

Conditions: Facial Paralysis
Interventions: Mindfulness Sessions, No Mindfulness Sessions; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: HIV
Interventions: Rapid HIV testing, Referral for HIV testing; Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 6,715 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 4
States / cities: Boston, Massachusetts • Dorchester, Massachusetts

Conditions: Resistant Hypertension
Interventions: Renal Denervation Only, Splanchnic Nerve Denervation; Device
Lead sponsor: Tulane University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Physical Inactivity, Sedentary Lifestlye
Interventions: ViaHabit; Behavioral
Lead sponsor: Louisiana State University and A&M College; Other
Eligibility: 45 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Chronic Lymphocytic Leukemia (CLL), Refractory Chronic Lymphocytic Leukemia
Interventions: Obinutuzumab, Roginolisib, Venetoclax; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: HIV Treatment
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Perceived Burdensomeness, Suicidal Ideation
Interventions: Give to Others (GO) Module, MATCH (Modular Approach to Therapy for Children) - Anxiety and Depression Modules, Safety Planning; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 12 Years to 17 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Postoperative Facial Ecchymosis, Postoperative Facial Edema
Interventions: ELIXIR MD Photobiomodulation (PBM) System; Device
Lead sponsor: Elixir MD Inc; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Dup15Q Syndrome
Interventions: Basmisanil, Placebo; Drug
Lead sponsor: Newleos Therapeutics, Inc.; Industry
Eligibility: 2 Years to 14 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Lower Back Pain (CLBP)
Interventions: Within-subject test of blinded study medications (Placebo, Hydromorphone, Gabapentin); Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 65 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Group A Streptococcal (GAS) Pharyngitis
Interventions: 10 day standard of care antibiotic treatment, 5 day short course antibiotic treatment; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 3 Years to 18 Years
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Accidental Falls, Movement Disorders (Incl Parkinsonism), Parkinson Disease (PD), Postural Balance, Postural Balance
Interventions: Manualized recreational therapy balance program; Behavioral
Lead sponsor: Oklahoma State University; Other
Eligibility: 50 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stillwater, Oklahoma

Conditions: Neuropathic Corneal Pain
Interventions: Urcosimod ophthalmic solution is a preservative-free topical ophthalmic product; supplied in unit dose ampoules; administered QID for 12-weeks., Vehicle Ophthalmic Solution; Drug · Other
Lead sponsor: Okyo Pharma Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Elective Surgery, Frail Elderly
Interventions: Automated referral, Usual Care Group; Device · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 80 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Fibromyalgia (FM), Posttraumatic Stress Disorder (PTSD)
Interventions: sham plus PEPC, tAN plus PEPC; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Kidney Transplant, Liver Transplant
Interventions: Letermovir; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Diabetes, Diabetes Type 2
Interventions: Integrated Digital Health (IDH) platform, Provider engagement; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Liver Diseases
Interventions: Ensure Plus Nutrition Shake, Novel MRI Software; Other · Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 7 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Irritable Bowel Syndrome
Interventions: Well-Being Intervention; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: HIV, Substance Abuse
Interventions: Tool to provide re-entry support and improve linkage to healthcare and social services; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Libido Disorder, Menopause, Sexual Dysfunction, Testosterone Deficiency
Interventions: Transdermal placebo gel, Transdermal testosterone gel; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Myeloproliferative Neoplasms (MPNs)
Interventions: WELL-MPN Digital App; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cognitive Impairment, Mild, Epilepsy, Memory Disorder, Memory Loss, Seizures
Interventions: COBENFY KarXT (50/20 mg), Control; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Glioma
Interventions: UR-ddPCR; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Mindfulness in Nonflaccid Facial Paralysis

HIV Testing in Community Health Center Dental Clinics

The RESPLASH Study

Roybal Via Habit Formation

Roginolisib Plus Obinutuzumab + Venetoclax in R/R CLL

Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care

Evaluation of a Brief, Scalable Module to Mitigate Suicidal Ideation Among Youth (Phase 2)

Perioperative Photobiomodulation in Facial Plastic Surgery

A Phase II Study of Basmisanil in Children and Adolescents With Dup15q Syndrome

Mechanistic Evaluation of Polypharmacy Effects for Pain

Short Versus Standard Amoxicillin for Pediatric Strep Throat

A Manualized Recreational Therapy Balance Program for Older Adults With Parkinson's and Movement Disorders

Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).

Hybrid III Trial of Automated Referral to Comprehensive Geriatric Assessment for Frail Older Surgical Patients

Treatment of Fibromyalgia and PTSD With Live and Inactive Vagus Nerve Stimulation With PEPC

Letermovir for R+ Study

Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study

Liver Micro Flow - MRI

A Well-Being Intervention for People With IBS

Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System

Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause

WELL-MPN: A Digital Lifestyle App for Patients With MPNs

Cholinergic Enhancement of Theta

Residual IDH1-Mutant Tumor Cell Quantification Study